DoW Arthritis Clinical Research Award
This grant funds clinical research on any type of arthritis focused on prevention, early diagnosis, or treatment, requiring community collaboration and preliminary data, with options for pilot or full-scale clinical trials.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 22, 2026: Pre-Application (Preproposal) | October 22, 2026: Full Application | October 27, 2026: End of Application Verification
Funding Amounts: ~$7.15M total; up to $1.3M (Level 1) or $3.25M (Level 2) per award over 4 years; ~4 awards expected
Summary: Supports clinical research on any type of arthritis to optimize patient outcomes, with required or encouraged community collaboration.
Key Information: Pre-application is required; Level 2 proposals must include a community collaborator.
Description
This opportunity, administered by the Department of the Army's USAMRAA, funds clinical research aimed at improving outcomes for people with arthritis, including service members and the broader public. The program supports studies addressing disease-specific factors or interventions, with a focus on generating evidence that can inform clinical care or policy. Applicants must address one of two focus areas: (1) Prevention and Early Diagnosis or (2) Treatment and Mitigation of Disease Progression/Burden. Two funding levels are offered: early-phase/pilot clinical research (Level 1) and full-scale clinical trials (Level 2). Community collaboration is strongly encouraged for Level 1 and required for Level 2.
